NCT03893890View on ClinicalTrials.gov

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

June 25, 2019

Study Completion Date

June 25, 2019

Conditions
Edematous Fibrosclerotic Panniculopathy
Interventions
BIOLOGICAL

Previously Treated with EN3835

No treatment to be administered - Observational only

Trial Locations (5)

10065

Endo Clinical Trial Site #2, New York

22911

Endo Clinical Trial Site #3, Charlottesville

33146

Endo Clinical Trial Site #1, Coral Gables

33756

Endo Clinical Trial Site #4, Clearwater

63090

Endo Clinical Trial Site #5, Washington

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY